Benefits and harms of CT screening for lung cancer: a systematic review
Context Lung cancer is the leading cause of cancer death. Most patients are diagnosed with
advanced disease, resulting in a very low 5-year survival. Screening may reduce the risk of …
advanced disease, resulting in a very low 5-year survival. Screening may reduce the risk of …
American Thoracic Society–European Respiratory Society classification of the idiopathic interstitial pneumonias: advances in knowledge since 2002
N Sverzellati, DA Lynch, DM Hansell, T Johkoh… - Radiographics, 2015 - pubs.rsna.org
In the updated American Thoracic Society–European Respiratory Society classification of
the idiopathic interstitial pneumonias (IIPs), the major entities have been preserved and …
the idiopathic interstitial pneumonias (IIPs), the major entities have been preserved and …
Screening for lung cancer: CHEST guideline and expert panel report
PJ Mazzone, GA Silvestri, S Patel, JP Kanne… - Chest, 2018 - Elsevier
Background Low-dose chest CT screening for lung cancer has become a standard of care in
the United States in the past few years, in large part due to the results of the National Lung …
the United States in the past few years, in large part due to the results of the National Lung …
Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate
GY Jin, D Lynch, A Chawla, K Garg, MC Tammemagi… - Radiology, 2013 - pubs.rsna.org
Purpose To determine the prevalence of interstitial lung abnormalities (ILAs) at initial
computed tomography (CT) examination and the rate of progression of ILAs on 2-year follow …
computed tomography (CT) examination and the rate of progression of ILAs on 2-year follow …
Screening for lung cancer: CHEST guideline and expert panel report
PJ Mazzone, GA Silvestri, LH Souter, TJ Caverly… - Chest, 2021 - Elsevier
Background Low-dose chest CT screening for lung cancer has become a standard of care in
the United States, in large part because of the results of the National Lung Screening Trial …
the United States, in large part because of the results of the National Lung Screening Trial …
[HTML][HTML] Profiling tumor-associated antibodies for early detection of non-small cell lung cancer
L Zhong, SP Coe, AJ Stromberg, NH Khattar… - Journal of Thoracic …, 2006 - Elsevier
Background A blood test for non-small cell lung cancer (NSCLC) may be a valuable tool for
use in a comprehensive lung cancer screening strategy. Here we report the potential of …
use in a comprehensive lung cancer screening strategy. Here we report the potential of …
[HTML][HTML] Recommendations for implementing lung cancer screening with low-dose computed tomography in Europe
G Veronesi, DR Baldwin, CI Henschke, S Ghislandi… - Cancers, 2020 - mdpi.com
Lung cancer screening (LCS) with low-dose computed tomography (LDCT) was
demonstrated in the National Lung Screening Trial (NLST) to reduce mortality from the …
demonstrated in the National Lung Screening Trial (NLST) to reduce mortality from the …
Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial
BACKGROUND: Despite the high survival rates reported for screening-detected cases, the
potential of screening of high-risk subjects for reducing lung cancer mortality is still …
potential of screening of high-risk subjects for reducing lung cancer mortality is still …
Thoracic low-dose CT image processing using an artifact suppressed large-scale nonlocal means
The x-ray exposure to patients has become a major concern in computed tomography (CT)
and minimizing the radiation exposure has been one of the major efforts in the CT field. Due …
and minimizing the radiation exposure has been one of the major efforts in the CT field. Due …
Interstitial lung diseases in a lung cancer screening trial
N Sverzellati, L Guerci, G Randi… - European …, 2011 - Eur Respiratory Soc
We assessed the prevalence of interstitial lung disease (ILD) in a cohort of smokers included
in a lung cancer screening trial. Two observers independently reviewed, for the presence of …
in a lung cancer screening trial. Two observers independently reviewed, for the presence of …